BrightFocus Foundation - Macular Degeneration Innovative Research Grants


Event details

Date 28.07.2022
Category Call for proposal
Aim: BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of age-related macular degeneration. This program is intended to provide support for high-risk/high-gain age-related macular degeneration research. Established investigators are particularly encouraged to apply, but the aims of the application must contain outside-the-box ideas that are novel in the field. Applicants who are experts in another field are encouraged to apply their talents to proposing innovative research in the macular degeneration field.

Duration:      3 years

Funding:       $ 600’000

Eligibility: Candidates must hold an MD, PhD, DVM, DO, OD or equivalent degree. Applicant must serve as the Principal Investigator on the project and have independent laboratory space. Postdoctoral fellows should not be named as Co-PI on Innovative Research awards. Applicants may currently be working in a non-profit, governmental, academic research institution, or at a for-profit including start-up and biotech institution.

How to Apply: MDR employs a two-tiered review process in which proposals are first submitted by Letter of Intent. Letters of intent must be submitted through proposalCENTRAL.  Instructions for use of the portal can be found here. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. Reviewers will invite the most enthusiastically reviewed Letters of Intent to submit a full application.

Letter of Intent deadline: 28-July-2022 (11:59 pm EST)

Further information
  • More information about the program in general is available here, and about the current call here.
  • The application portal can be found here.
  • For any other questions, please contact the Research Office.

Practical information

  • General public
  • Free


Event broadcasted in